Brief: Simulations Plus Collaborates With Pharmaceutical Firm
23/06/2022 13:43
June 23 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS COLLABORATES WITH MULTINATIONAL
PHARMACEUTICAL
COMPANY TO PROVIDE MODELING & SIMULATION SUPPORT FOR COVID-19
TREATMENT
Source text for Eikon: ID:nBw1v2fRya
Further company coverage: SLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump